- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Human Immunodeficiency Virus (HIV)
- Meeting Date: July 2005
Abacavir Sulfate with Lamivudine – July 2007
Abacavir Sulfate with Lamivudine, tablet, 600 mg (base) - 300 mg, Kivexa®, July 2005
Last updated
27 June 2025
